Sector News

ICL to sell pharma, cosmetics and gypsum businesses to One Rock Capital Partners

May 26, 2015
Chemical Value Chain
Israel Chemicals Ltd. (ICL; Tel Aviv) says that its performance products segment has agreed to sell the company’s Germany-based pharmaceutical, cosmetics and gypsum (PCG) businesses to an affiliate of One Rock Capital Partners (New York), a private equity firm active in the chemicals industry. The share and asset purchase agreement is expected to close in the near term, ICL says. Financial details of the deal have not been disclosed. ICL’s PCG business units are engaged in the production of active ingredients for antacids and antiperspirants, as well as products for dental applications. The sale of the PCG business units is part of ICL’s strategy to divest its non-core businesses to focus on its core businesses in the agriculture, food and engineered materials markets and to optimize its positioning in those markets. As part of the strategy to divest non-core businesses, ICL, earlier this year, completed the sale of its businesses that produce alumina compounds, paper chemicals, and water treatment chemicals to Kurita Water Industries (Tokyo), Japan’s leading water treatment company, for €250 million ($272 million). Last December, ICL also agreed to sell its Rhenoflex business unit based at Ludwigshafen and in China to Findos Investor (Munich), an independent, midmarket private equity fund. Rhenoflex is a leading supplier of high-end shoe reinforcement materials and orthopedic parts to leading brands in the global footwear industry.
 
One Rock’s purchase of the PCG businesses is in line with its investment strategy and will provide One Rock with an opportunity to expand its activities in the global chemicals industry, ICL says.
 
 “ICL performance products intends to use the proceeds from the sale of our PCG businesses to strengthen our core businesses in the food and engineered materials markets, and to expand our global presence, especially in emerging markets,” says ICL performance products segment’s president and CEO, Mark Volmer. “We are certain that we have found an optimal owner for our PCG units that will develop their businesses and increase their activities globally,” Volmer says.
 
Earlier this year, One Rock Capital purchased a stake in Compass Chemical (Smyrna, GA), a maker of organophosphates, for an undisclosed amount.
 
By Deepti Ramesh
 

comments closed

Related News

May 21, 2022

Sika opens new manufacturing plant in Bolivia 

Chemical Value Chain

Sika AG (Baar, Switzerland) has opened a new plant in Santa Cruz de la Sierra, thus doubling its production capacity for mortar and concrete admixtures in Bolivia. With this new facility in one of the country’s main industrial agglomerations, Sika is positioning itself for continued growth in the dynamic Bolivian construction market.

May 21, 2022

Chevron increases renewable fuel market share with REG acquisition

Chemical Value Chain

Chevron Corporation (NYSE: CVX) and Renewable Energy Group, Inc. (NASDAQ: REGI) (REG) announced on Monday a definitive agreement under which Chevron will acquire the outstanding shares of REG in an all-cash transaction valued at $3.15 billion, or $61.50 per share.

May 21, 2022

Lotte Chemical to invest $8 bn on hydrogen energy, battery materials by 2030

Chemical Value Chain

Lotte Chemical Corp. will invest 10 trillion won ($8 billion) on hydrogen and battery materials through 2030 to achieve annual revenue of 50 trillion won and carbon neutrality. The Korean chemical producer on Thursday unveiled its new corporate vision outlining key corporate strategies with focus on growth through hydrogen energy and battery materials businesses.